RPRX Stock Price | Royalty Pharma Plc P/E, Revenue, EPS, & Forecasts

Royalty Pharma Plc • RPRX

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

Calendar

event

Ex dividend date

14 Nov 2025

calendar_clock

Next Dividend Payment

10 Dec 2025

About Royalty Pharma Plc

Ticker

RPRX

Trading on

NASDAQ

ISIN

GB00BMVP7Y09

Industry

Biotechnology

Sector

Healthcare

CEO

Pablo Gerardo Legorreta

Headquarters

110 East 59th Street, New York, NY, United States, 10022

Employees

Website

royaltypharma.com

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Metrics

BasicAdvanced

Market cap

$22.8B

P/E ratio

22.37

EPS

$1.75

Dividend Yield

2.20%

Beta

0.47

Forward P/E ratio

11.74

EBIDTA

$1.5B

Ex dividend date

2025-11-14

Price & volume

Market cap

$22.8B

Average daily volume

4.5M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.87

Dividend yield

2.20%

Forward dividend per share

$0.88

Forward dividend yield

2.22%

Payout ratio

23.66%

Valuation

P/E ratio

22.37

Forward P/E

11.74

PEG ratio

1.74

Trailing P/E

22.37

Price to sales

9.72

Price to book

2.64

Earnings

EPS

$1.75

EPS estimate (current quarter)

$1.04

EPS estimate (next quarter)

$1.28

EBITDA

$1.5B

Revenues (TTM)

$2.35B

Revenues per share (TTM)

$5.41

Technicals

Beta

0.47

52-week High

$41.24

52-week Low

$23.46

50-day moving average

$37.60

200-day moving average

$35.17

Short ratio

6.62

Short %

5.71%

Management effectiveness

ROE (TTM)

13.10%

ROA (TTM)

5.22%

Profit margin

32.55%

Gross profit margin

$2.5B

Operating margin

70.27%

Growth

Quarterly earnings growth (YoY)

-45.20%

Quarterly revenue growth (YoY)

7.90%

Share stats

Outstanding Shares

427M

Float

375M

Insiders %

8.85%

Institutions %

81.82%

Analyst Insights & forecasts

75% Buy

25% Hold

0% Sell

Based on information from 8 analysts.

Average price target

$45.98

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

$0.35

$0.25

40.00%

Q4 • 24Beat

$1.06

$0.95

11.58%

Q1 • 25Beat

$1.14

$1.03

10.68%

Q2 • 25Beat

$1.17

$1.04

12.50%

Q3 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$579M

$30.2M

5.21%

Q2 • 25

$609M

$288M

47.30%

Q3 • 25

5.29%

855.12%

807.11%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$18.3B

$8.82B

48.14%

Q2 • 25

$19.3B

$9.73B

50.27%

Q3 • 25

5.59%

10.28%

4.44%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$427M

$-312M

$-513M

$427M

Q2 • 25

$640M

$-958M

$568M

$641M

Q3 • 25

49.81%

207.17%

-210.71%

50.07%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Royalty Pharma Plc share?

Royalty Pharma Plc shares are currently traded for undefined per share.

How many shares does Royalty Pharma Plc have?

Royalty Pharma Plc currently has 427M shares.

Does Royalty Pharma Plc pay dividends?

Yes, Royalty Pharma Plc does pay dividends.

What is Royalty Pharma Plc 52 week high?

Royalty Pharma Plc 52 week high is $41.24.

What is Royalty Pharma Plc 52 week low?

Royalty Pharma Plc 52 week low is $23.46.

What is the 200-day moving average of Royalty Pharma Plc?

Royalty Pharma Plc 200-day moving average is $35.17.

Who is Royalty Pharma Plc CEO?

The CEO of Royalty Pharma Plc is Pablo Gerardo Legorreta.

How many employees Royalty Pharma Plc has?

Royalty Pharma Plc has 0 employees.

What is the market cap of Royalty Pharma Plc?

The market cap of Royalty Pharma Plc is $22.8B.

What is the P/E of Royalty Pharma Plc?

The current P/E of Royalty Pharma Plc is 22.37.

What is the EPS of Royalty Pharma Plc?

The EPS of Royalty Pharma Plc is $1.75.

What is the PEG Ratio of Royalty Pharma Plc?

The PEG Ratio of Royalty Pharma Plc is 1.74.

What do analysts say about Royalty Pharma Plc?

According to the analysts Royalty Pharma Plc is considered a buy.